Tissue Selective drug discovery

Bonito biosciences is a seed-stage biotechnology company developing a groundbreaking platform to discover small molecule, peptide and antibody agents that can be directly conjugated to their therapeutic payload and selectively targeted to any cell type or tissue of interest.

Harnessing the power of AI to generate novel delivery molecules

Unlocking Next Generation Delivery Vehicles

Bonito Biosciences is dedicated to solving one of the most critical challenges in medicine today: tissue-selective drug delivery for oligonucleotides and other macromolecules.

experience & leadership

Bonito is led by an experienced team of entrepreneurs and innovative scientists with a track record of pioneering display technologies and oligonucleotide therapeutics.

Reach out